专利号:US-8309099-B2 优先权日:2000-04-28 标 题:DNA transfection system for the generation of negative strand RNA virus 发明人:HOFFMANN ERICH 权利人:HOFFMANN ERICH; ST JUDE CHILDRENS RES HOSPITAL 摘要:The present invention is based on the development of a dual promoter system (preferably a RNA pol I-pol II system) for the efficient intracellular synthesis of viral RNA. The resultant minimal plasmid-based system may be used to synthesize any RNA virus, preferably viruses with a negative single stranded RNA genome. The viral product of the system is produced when the plasmids of the system are introduced into a suitable host cell. One application of the system is production of attenuated, reassortant influenza viruses for use as antigens in vaccines. The reassortant viruses generated by cotransfection of plasmids may comprise genes encoding the surface glycoproteins hemagglutinin and neuraminidase from an influenza virus currently infecting the population and the internal genes from an attenuated influenza virus. An advantageous property of the present invention is its versatility; the system may be quickly and easily adapted to synthesize an attenuated version of any RNA virus. Attenuated or inactivated RNA viruses produced by the present invention may be administered to a patient in need of vaccination by any of several routes including intranasally or intramuscularly.
专利号:US-2024287041-A1 优先权日:2021-05-20 标题 :Methods of synthesis of heteroaryl derivatives of triazolyl acrylamides and crystalline forms 发明人:BALOGLU ERKAN; AUSTAD BRIAN C; ROE DAVID G; KEDUC ANDREW; GOTTSCHLING STEPHEN EDMUND; HECKER EVAN 权利人:KARYOPHARM THERAPEUTICS INC 摘要:The present invention relates to a method of preparing a compound represented by structural formula (VII), comprising reacting a compound represented by structural formula (II), with a compound represented by structural formula (III), in a solvent, in the presence of a Pd catalyst and one or more inorganic bases under conditions suitable to prepare a compound represented by structural formula (VII): The values and example values of the variables in structural formulas (VII), (II), and (III) are defined herein. The present invention also relates to crystalline Forms I and II of the compound represented by Structural Formula (VII), the use of the crystalline Forms in treating disease or disorders associated with CRM1 and method of preparing the crystalline Forms.
专利号:US-2009068082-A1 优先权日:2002-01-02 标题 :Synthesis and characterization of a highly stable amorphous silicon hydride as the product of a catalytic hydrogen plasma reaction 发明人:MILLS RANDELL L 权利人:BLACKLIGHT POWER INC 摘要:This invention relates to a highly stable silicon hydride (SiH(1/p)) surface coating formed from high binding energy hydride ions. SiH(1/p) may be synthesized in a cell for the catalysis of atomic hydrogen to form novel hydrogen species and/or compositions of matter containing new forms of hydrogen. The reaction may be maintained by a microwave plasma of a source of atomic hydrogen, a source of catalyst, and a source of silicon.
专利号:WO-2022246227-A1 优先权日:2021-05-20 标 题:Methods of synthesis of heteroaryl derivatives of triazolyl acrylamides and crystalline forms
专利号:EP-4341253-A1 优先权日:2021-05-20 标题 :Methods of synthesis of heteroaryl derivatives of triazolyl acrylamides and crystalline forms
专利号:US-2005202173-A1 优先权日:2002-05-01 标题 :Diamond synthesis 发明人:MILLS RANDELL L 摘要:The present invention relates to a cell, system, and methods to form diamond from carbon in a plasma formed or assisted by the catalysis of atomic hydrogen to lower energy states.
1: Wright MG. Micro-encapsulated aspirin (Levius) compared with aloxiprin (Palaprin Forte) in the treatment of rheumatoid arthritis. J Int Med Res. 1976;4(4):272-5. doi: 10.1177/030006057600400410. 15:56-62. doi: 10.1111/j.2042-7158.1963.tb12743.x. 7(2):127-30. doi: 10.1185/03007998009112039. 3(1):59-62. 52(604):71-5. doi: 10.1136/pgmj.52.604.71. 6: Vojtisek O, Kanková D, Pavelka K, Hándlová D. Wirkungsvergleich zwischen Niflumsäure und Aloxiprin bei Kranken mit progredient chronischer Polyarthritis im Doppelblindversuch [Comparison of the effects of niflumic acid and aloxiprin in patients with progressive chronic rheumatoid arthritis in a double blind trial]. Arzneimittelforschung. 1975 Aug;25(8):1308-11. German. 208(244):248-51. 4(3):323-31. 22(9):392-4.